Biopharmaceutical CMO Market size was valued at USD 30.22 billion in 2022 and is expected to reach at USD 79.77 billion by 2030, and grow at a CAGR of 12.9% over the forecast period of 2023-2030. This impressive surge is driven by a confluence of factors, including: Rising demand for biologics and complex therapies: The increasing prevalence of chronic diseases and the development of...

Heparin Market was estimated at USD 7.5 billion in 2022 and is poised to reach at 9.20 billion in 2030 anticipated to expand at a compound annual growth rate approx. CAGR of 2.6% for the forecast period of 2023-2030. This impressive surge is driven by a confluence of factors, including: Increased prevalence of cardiovascular diseases and venous thromboembolism (VTE): Rising numbers...